Pulmonx Corporation (LUNG)

HashiCorp Statistics

Total Valuation

Pulmonx has a market cap or net worth of $64.81 million. The enterprise value is $37.42 million.

Market Cap	64.81M
Enterprise Value	37.42M

Important Dates

The last earnings date was Wednesday, July 30, 2025, after market close.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmonx has 40.26 million shares outstanding. The number of shares has increased by 3.35% in one year.

Current Share Class	40.26M
Shares Outstanding	40.26M
Shares Change (YoY)	+3.35%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	2.62%
Owned by Institutions (%)	91.39%
Float	39.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.71
Forward PS	0.62
PB Ratio	0.94
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.82.

Current Ratio	5.35
Quick Ratio	4.46
Debt / Equity	0.82
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.66

Financial Efficiency

Return on equity (ROE) is -66.88% and return on invested capital (ROIC) is -24.35%.

Return on Equity (ROE)	-66.88%
Return on Assets (ROA)	-21.57%
Return on Invested Capital (ROIC)	-24.35%
Return on Capital Employed (ROCE)	-44.25%
Revenue Per Employee	$311,165
Profits Per Employee	-$195,670
Employee Count	291
Asset Turnover	0.57
Inventory Turnover	1.47

Taxes

In the past 12 months, Pulmonx has paid $542,000 in taxes.

Income Tax	542,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.70% in the last 52 weeks. The beta is 0.43, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-76.70%
50-Day Moving Average	2.93
200-Day Moving Average	5.47
Relative Strength Index (RSI)	28.06
Average Volume (20 Days)	743,534

Short Selling Information

The latest short interest is 1.44 million, so 3.58% of the outstanding shares have been sold short.

Short Interest	1.44M
Short Previous Month	1.32M
Short % of Shares Out	3.58%
Short % of Float	3.67%
Short Ratio (days to cover)	4.35

Income Statement

In the last 12 months, Pulmonx had revenue of $90.55 million and -$56.94 million in losses. Loss per share was -$1.43.

Revenue	90.55M
Gross Profit	66.16M
Operating Income	-55.20M
Pretax Income	-57.29M
Net Income	-56.94M
EBITDA	-54.77M
EBIT	-55.20M
Loss Per Share	-$1.43

Balance Sheet

The company has $84.23 million in cash and $56.83 million in debt, giving a net cash position of $27.40 million or $0.68 per share.

Cash & Cash Equivalents	84.23M
Total Debt	56.83M
Net Cash	27.40M
Net Cash Per Share	$0.68
Equity (Book Value)	69.09M
Book Value Per Share	1.71
Working Capital	97.57M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 73.07%, with operating and profit margins of -60.96% and -62.88%.

Gross Margin	73.07%
Operating Margin	-60.96%
Pretax Margin	-62.28%
Profit Margin	-62.88%
EBITDA Margin	-60.49%
EBIT Margin	-60.96%
FCF Margin	n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.35%
Shareholder Yield	-3.35%
Earnings Yield	-87.85%
FCF Yield	n/a

Analyst Forecast

The average price target for Pulmonx is $7.66, which is 375.78% higher than the current price. The consensus rating is "Buy".

Price Target	$7.66
Price Target Difference	375.78%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	32.19%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2